Entera Bio Ltd (ENTX)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Entera Bio Ltd (ENTX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	0.042	0.082	0.042
Cost Of Revenue	-	-	0.042	0.082	0.042
Gross Profit	-	-	-	-	-
Operating Expenses	22.04% 3.256	2.668	2.563	2.337	3.021
Benefits Costs and Expenses	-	-	-	2.426	3.063
Costs And Expenses	22.04% 3.256	2.668	2.605	2.426	3.063
Operating Income/Loss	22.04% -3.256	-2.668	-2.563	-2.337	-3.021
Nonoperating Income/Loss	366.67% 0.056	0.012	-0.004	-0.007	-
Income/Loss From Continuing Operations Before Tax	20.48% -3.20	-2.656	0.042	-2.344	-3.021
Income/Loss From Continuing Operations After Tax	20.48% -3.20	-2.656	-2.567	-2.358	-3.021
Net Income/Loss	20.48% -3.20	-2.656	-2.567	-2.358	-3.021
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.54% 47.09	46.84	43.38	0.4867	37.64
Diluted Average Shares	0.54% 47.09	46.84	43.38	0.4867	37.64
Basic Earnings Per Share	16.67% 0.07	0.06	0.06	0.06	0.08
Diluted Earnings Per Share	16.67% 0.07	0.06	0.06	0.06	0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RVMD

$99.29

1.20%

ROIV

$27.80

0.00%

MRNA

$52.37

0.06%

BNTX

$89.31

0.77%

INSM

$144.00

0.91%

ONC

$282.72

0.15%